After a delay of several years, people living with multiple sclerosis in England will finally be able to get NHS access to ...
GSK has won FDA approval for Jideytro, a drug at the heart of its $10.6 billion acquisition of Nuvalent earlier this year – ...
China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder ...
Life sciences equipment and consumable manufacturer Repligen has reached a deal to buy cell therapy specialist BioLife ...
Donald Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, as part of a ...
Kaken Pharmaceutical has revealed the phase 3 results that supported its recent marketing application for serabelisib in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results